MedPath

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

Completed
Conditions
Prostatic Neoplasms
Quality of Life
Interventions
Procedure: therapeutic management of the prostate Cancer as usual
Registration Number
NCT02854982
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
900
Inclusion Criteria
  • prostate cancer diagnosed from 1 December 2011 to 31 December 2014
  • under 75 and residing in the Hérault department at diagnosis
  • recruited in the EPICAP study

Exclusion criteria:

  • having relapsed in the range
  • non-exposed group:

Inclusion Criteria:

  • controls (without prostate cancer) recruited in the EPICAP study
  • matched to cases on age (5 years)
  • residing in the Hérault department

Exclusion criteria:

  • diagnosis of prostate cancer set in the range
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Prostate Cancertherapeutic management of the prostate Cancer as usualGroup drawn of the case group of the case control study, entitled EPICAP
Primary Outcome Measures
NameTimeMethod
EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)3 years from diagnosis for cases of prostate cancer and from recruitment for controls
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath